5th NASH Summit 2021

Temas de la conferencia
Masterfully combining the hottest insights on NASH from 65+ strong speaker faculty, including 45+ brand new speakers from the FDA, EMA, Takeda, Eli Lilly, Gilead, Pfizer, AstraZeneca, Ionis, Novo Nordisk and more, the 5th NASH Summit is your best opportunity to unite with fellow NASH drug developers to gain critical updates on the trailblazing research you need to meaningfully reassess your therapeutic approach and optimize your pipeline strategy for the future.

Organizador profesional (PCO)
Hanson Wade

Observaciones
Brochure: https://go.evvnt.com/848618-3?pid=4832

Speakers: Christopher Jones Director of Biology Terns Pharmaceuticals, Elias Papatheodoru Chief Executive Officer Genkyotex and more

https://go.evvnt.com/848618-2?pid=4832

Ms. Kaltrina Kastrati